Charles River Narrows FY2023 Adj EPS Guidance from $10.30-$10.90 to $10.50 - $10.70 vs. $10.56 Est;
Portfolio Pulse from Benzinga Newsdesk
Charles River Laboratories has revised its FY2023 adjusted EPS guidance from $10.30-$10.90 to $10.50 - $10.70, which is in line with the estimate of $10.56. The company's revenue growth guidance for 2023 has been narrowed from 2.5% – 4.5% to 2.5% – 3.5%.
November 08, 2023 | 12:20 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Charles River Laboratories has revised its FY2023 adjusted EPS guidance, which is in line with estimates. This could potentially reassure investors about the company's financial stability.
Charles River Laboratories has revised its FY2023 adjusted EPS guidance to $10.50 - $10.70, which is in line with the estimate of $10.56. This shows that the company's financial performance is expected to be stable, which could reassure investors and have a neutral impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100